India have set up the body Health Technology Assessment in India (HTAIn) under the Department of Health Research (DHR), Ministry of Health and Family Welfare (MoHFW). This marks India’s ongoing commitment to using HTA to extend healthcare services and pursue Universal Health Coverage. HITAP are thri

HITAP in collaboration with the Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) is hosting a health technology assessment (HTA) workshop on 3-5 October 2019.In this workshop, the participants will learn:What is HTA?How can the value for money of a health intervention be

The Health Intervention and Technology Assessment Program (HITAP) has supported the development of Health Technology Assessment (HTA) in India by building technical capacity and knowledge through collaborations with several academic institutions in India on HTA. HITAP recently partnered with the Jaw

In October 2018, three researchers from the Christian Medical College (CMC) Vellore spent a week at the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, to learn about health technology assessments and to apply costing analyses on two cost-ofillness

HTA Workshop and Conference in Chandigarh, India iDSI theme: Strengthening Health Systems and Institutions The Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India, hosted two HTA events in February 2018 in collaboration with partners, including t

From 23rd to 25th February 2018, three members from HITAP’s International Unit (HIU) went to Chandigarh, India. Two separate events occurred in Chandigarh during this time. The first was the 7th International Fellowship on Health Technology Assessment, a week-long HTA training workshop from 19th to

On 29 January 2013, a side meeting entitled “the establishment and evolution of health technology assessment organisations in low- and middle-income countries”, which was co-organized by HTAsiaLink and NICE international, intended to create an open space for sharing, learning and inspiring participa

(Reuters Health) – A study of nearly 190,000 young women injected with Merck & Co’s human papillomavirus vaccine Gardasil found no new safety concerns.Researchers said the only side effects they observed – rare cases of skin infections and fainting – were benign and expected.“This analysis was v

Yot Teerawattananon, Alia Luz* , Songyot Pilasant, Suteenoot Tangsathitkulchai, Sarocha Chootipongchaivat, Nattha Tritasavit, Inthira Yamabhai and Sripen Tantivess Abstract Background: It is very challenging for resource-limited settings to introduce universal health coverage (UHC), particular

Situation of Clean Air Rooms and Air Purifiers in Thailand Thailand continues to experience persistent fine particulate matter with a diameter of 2.5 micrometers or less (PM2.5), posing significant risks to public health, particularly among vulnerable populations. About 13.6 mill